Secondary aims were to assess any associations and/ or correlations between serum NfL levels and cognitive defects, white matter alterations at brain MRI, other clinic-diagnostic features (disease form and duration, skeletal muscle and respiratory involvement, and nCTG in leukocytes), and demographic parameters in DM1 patients. The gene discussed is NEFL; the disease is myotonic dystrophy type 1.